Combination of rituximab with combined pulse-therapy with high doses of methylprednisolone and cyclophosphamide : effects on immunomorphological and functional disturbances of the salivary glands in a patient with Sjogren's disease and MALT-lymphoma
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2008 |
|---|---|
| Erschienen: |
2008 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:80 |
|---|---|
| Enthalten in: |
Terapevticheskii arkhiv - 80(2008), 5 vom: 06., Seite 76-9 |
| Sprache: |
Russisch |
|---|
| Beteiligte Personen: |
Vasil'ev, V I [VerfasserIn] |
|---|
| Anmerkungen: |
Date Completed 23.09.2008 Date Revised 19.11.2015 published: Print Citation Status MEDLINE |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
NLM180555146 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM180555146 | ||
| 003 | DE-627 | ||
| 005 | 20231223155702.0 | ||
| 007 | tu | ||
| 008 | 231223s2008 xx ||||| 00| ||rus c | ||
| 028 | 5 | 2 | |a pubmed24n0602.xml |
| 035 | |a (DE-627)NLM180555146 | ||
| 035 | |a (NLM)18590121 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a rus | ||
| 100 | 1 | |a Vasil'ev, V I |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Combination of rituximab with combined pulse-therapy with high doses of methylprednisolone and cyclophosphamide |b effects on immunomorphological and functional disturbances of the salivary glands in a patient with Sjogren's disease and MALT-lymphoma |
| 264 | 1 | |c 2008 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a Date Completed 23.09.2008 | ||
| 500 | |a Date Revised 19.11.2015 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Case Reports | |
| 650 | 4 | |a Journal Article | |
| 650 | 7 | |a Antibodies, Monoclonal |2 NLM | |
| 650 | 7 | |a Antibodies, Monoclonal, Murine-Derived |2 NLM | |
| 650 | 7 | |a Glucocorticoids |2 NLM | |
| 650 | 7 | |a Immunologic Factors |2 NLM | |
| 650 | 7 | |a Rituximab |2 NLM | |
| 650 | 7 | |a 4F4X42SYQ6 |2 NLM | |
| 650 | 7 | |a Cyclophosphamide |2 NLM | |
| 650 | 7 | |a 8N3DW7272P |2 NLM | |
| 650 | 7 | |a Methylprednisolone |2 NLM | |
| 650 | 7 | |a X4W7ZR7023 |2 NLM | |
| 700 | 1 | |a Kokosadze, N V |e verfasserin |4 aut | |
| 700 | 1 | |a Logvinenko, O A |e verfasserin |4 aut | |
| 700 | 1 | |a Nikitin, E A |e verfasserin |4 aut | |
| 700 | 1 | |a Mitrikov, B V |e verfasserin |4 aut | |
| 700 | 1 | |a Rodionova, E B |e verfasserin |4 aut | |
| 700 | 1 | |a Varlamova, E Iu |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Terapevticheskii arkhiv |d 1949 |g 80(2008), 5 vom: 06., Seite 76-9 |w (DE-627)NLM000055425 |x 0040-3660 |7 nnns |
| 773 | 1 | 8 | |g volume:80 |g year:2008 |g number:5 |g day:06 |g pages:76-9 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 80 |j 2008 |e 5 |b 06 |h 76-9 | ||